GST Reform: NPPA Directs Drug Makers to Pass on Benefits Through Revised MRPs from Sept 22

The NPPA has directed "drug makers to pass on benefits through revised MRPs from September 22" following recent GST reforms. This is a significant move for the company, as it faces a challenging business environment. The move is a significant step towards a more user-friendly and less intrusive business environment, is aimed at promoting business growth while being sensitive to the practical difficulties faced by businesses. This is a crucial reminder to all businesses that they must be diligent in their dealings.